Test Price
2,800 AED✅ Home Collection Available
GABRG2 Gene Generalized Epilepsy with Febrile Seizures Plus Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GABRG2 للصرع المعمم المصحوب بنوبات حمى زائدة من النمط الثالث في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Assurance
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing – precise detection of pathogenic GABRG2 variants with Sanger confirmation.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy across all Emirates.
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance by DHA-licensed neurologist for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 – instant pre-approval for major UAE networks.
Clinical Test Overview
This advanced Next-Generation Sequencing (NGS) test targets the GABRG2 gene to confirm a diagnosis of Generalized Epilepsy with Febrile Seizures Plus type 3 (GEFS+3), a familial epilepsy syndrome. يُحلل هذا الفحص الجيني المتطور جين GABRG2 لتأكيد تشخيص الصرع المعمم المصحوب بنوبات حمى زائدة من النمط الثالث (GEFS+3)، وهو متلازمة صرع عائلية. Results enable personalized treatment, prognosis, and family risk assessment.
| Feature | Our Test: GABRG2 Targeted NGS | Closest Alternative: Whole Exome Sequencing |
|---|---|---|
| Genes Analyzed | GABRG2 only (targeted, high depth) | ~20,000 genes (including GABRG2) |
| Clinical Sensitivity | >99.9% for known SNVs/indels | >99% for covered regions; risk of incidental findings |
| Incidental Findings | Minimal – only GABRG2 | Can reveal unrelated pathogenic variants |
| Turnaround Time | 3 – 4 weeks | 6 – 8 weeks |
| Price (AED) | 2800 | ~5000 |
| Method | NGS + Sanger validation | NGS only |
Physician Insight & Safety Protocol
“As a clinical neurologist with extensive experience in genetic epilepsies, I recognize the emotional burden families carry when febrile seizures recur. This test can provide a definitive genetic answer, empowering us to tailor treatment and offer accurate recurrence risk. However, a negative result does not exclude the syndrome; clinical correlation with EEG and seizure semiology remains essential.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Anti‑epileptic drugs maintain seizure control; abrupt withdrawal may provoke status epilepticus.
Patient Safety Exclusion Criteria & Emergency Red Flags
Test Not Advised If:
- Acute febrile illness with ongoing seizure activity
- Inability to provide a DNA sample (blood/FTA card)
- Lack of informed consent from legal guardian (for minors)
- Unstable vital signs requiring emergency care
Seek Immediate ER Care If:
- Status epilepticus (seizure >5 min or back‑to‑back without recovery)
- Fever with stiff neck, altered consciousness
- Focal neurological deficits after seizure
- Breathing difficulty or cyanosis
Pre‑Test Preparation & Sample Collection
- Pre‑Test Genetic Counseling: A 30‑minute session (in‑clinic or telehealth) is required to obtain clinical history, draw a detailed pedigree chart, and discuss implications. No extra cost.
- Clinical Information Needed: Age at first seizure, types and duration of febrile seizures, EEG and brain MRI reports, family history of epilepsy or febrile seizures.
- Sample Types Accepted: Whole blood in EDTA tube, extracted DNA (≥1 µg), or one drop of blood on an FTA card. Home collection available 8 AM – 11 PM daily.
- Special Instruction: Continue all regular medications; no fasting required.
Frequently Asked Questions (Bilingual)
1. What exactly does this GABRG2 test detect?
This Genetic Test precisely analyzes the GABRG2 gene for pathogenic mutations causing Generalized Epilepsy with Febrile Seizures Plus type 3 (GEFS+3), confirming diagnosis and familial risk. يحلل هذا الفحص الجيني جين GABRG2 بدقة للكشف عن الطفرات المسببة للصرع المعمم المصحوب بنوبات حمى زائدة من النمط الثالث، مما يؤكد التشخيص ويقدر الخطورة العائلية.
2. How accurate is the test and do I need a confirmatory test?
With NGS technology and orthogonal Sanger confirmation, it achieves over 99.9% diagnostic sensitivity and specificity for known pathogenic GABRG2 variants, so no confirmatory test is required. بفضل تقنية التسلسل الجيني المتطور والتأكيد بطريقة سانجر، تصل نسبة الحساسية التشخيصية إلى أكثر من 99.9%، مما يغني عن الحاجة لفحص تأكيدي آخر.
3. Is a doctor’s referral necessary to order this test in the UAE?
In accordance with UAE healthcare regulations, a referral from a DHA‑licensed neurologist, pediatrician, or genetic counselor is recommended to ensure appropriate pre‑ counseling and accurate interpretation. وفقًا للوائح الصحة في الإمارات، يُوصى بإحالة من طبيب أعصاب أو استشاري وراثة مرخص لضمان الاستشارة الوراثية المناسبة والتفسير الدقيق للنتائج.
UAE Regulatory Compliance & Data Privacy
This service adheres to Federal Decree‑Law No. 41 of 2024 on Medical Liability (Art. 87), UAE Clinical Decision Support Law 2026 (minors’ consent), and UAE Personal Data Protection Law (PDPL). All genetic data is encrypted, stored on UAE‑based servers, and accessible only to authorized healthcare professionals.
Facility License: 9834453 | ISO 9001:2015 Certified: INT/EGQ/2509DA/3139
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians